About
License, develop, and commercialize product candidates
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
315
By Phase
PHASE1: 3PHASE1/PHASE2: 1PHASE3: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06600477Lead Sponsor
A Study of Olanzapine After Intranasal and Intramuscular Administration
PHASE1Completed
24 participants
Started: Oct 16, 2023 · Completed: Nov 1, 2023
NCT05076838Lead Sponsor
Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy
PHASE1/PHASE2Completed
35 participants
Started: Nov 8, 2021 · Completed: Mar 11, 2025
NCT02724423Lead Sponsor
Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
PHASE1Completed
57 participants
Started: Jun 30, 2016 · Completed: Sep 10, 2019
NCT02721069Lead Sponsor
Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects
PHASE3Completed
175 participants
Started: Apr 11, 2016 · Completed: Jul 23, 2020
NCT01364558Collaborator
A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
PHASE1Completed
24 participants
Started: Feb 28, 2011 · Completed: Apr 30, 2011
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...